A snapshot of Germany, one of the European pharma hotspots featured in PharmaBoardroom’s latest report, InFigures: European Pharma Hotspots 2022.
With the largest market value in Europe, Germany remains at the top of the region’s pharmaceutical markets.
Additionally, Germany leads the way in terms of pharma industry R&D spending, ahead of Switzerland, the UK and France, with EUR 8,466 million spent on research according to figures provided by The European Federation of Pharmaceutical Industries and Associations (EFPIA).
The evolution of German Pharma R&D Spending:
Germany’s most valuable pharmaceuticasl/biotech companies:
Get all the data in: InFigures: European Pharma Hotspots 2022
